ClassID:

20298

A61K31/365 - page 3 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin Lactones

Recent Application in this class:
#601
20190185413
2019-06-20

BETA-SUBSTITUTED BETA-AMINO ACIDS AND ANALOGS AS CHEMOTHERAPEUTIC AGENTS AND USES THEREOF

#602
20190183855
2019-06-20

COMPOSITION FOR TREATING HEPATITIS B, AND METHOD FOR EVALUATING REPLICATION ACTIVITY OF HEPATITIS B VIRUS

#603
20190175699
2019-06-13

Angiopoietin-based interventions for treating cerebral malaria

#604
20190151342
2019-05-23

COMPOSITIONS THAT INCLUDE ANTHOCYANIDINS AND METHODS OF USE

#605
20190151283
2019-05-23

NON-STEROIDAL SELECTIVE GLUCOCORTICOID RECEPTOR AGONISTIC MODULATORS (SEGRAMs) AND USES THEREOF

#606
20190142794
2019-05-16

Pharmaceutical composition containing Ginkgolide B and ADP receptor antagonist, preparation method thereof and use thereof

#607
20190134230
2019-05-09

Challenge test for diagnosing subtypes of ASD

#608
20190134229
2019-05-09

Method of identifying ASD phenotype 1 patients

#609
20190134152
2019-05-09

Treatment of a subtype of ASD

#610
20190125814
2019-05-02

Extract of andrographis paniculata for cognitive enhancement

#611
20190125724
2019-05-02

Prevention and treatment of viral infections

#612
20190125721
2019-05-02

METHODS AND COMPOSITIONS FOR TREATMENT OF RETT SYNDROME

#613
20190117714
2019-04-25

Use of a composition for lowering cholesterol level in a mammal, a method for its preparation and a product and a food additive comprising said composition

#614
20190117683
2019-04-25

Alginate oligomers for the treatment or prevention of microbial overgrowth in the intestinal tract

#615
20190117565
2019-04-25

Soft Chewable Pharmaceutical Product

#616
20190117564
2019-04-25

Soft Chewable Pharmaceutical Products

#617
20190111023
2019-04-18

Use of acyl-homoserine lactone derivatives as anti-thrombotic agents

#618
20190105305
2019-04-11

Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof

#619
20190105299
2019-04-11

LYMPH DIRECTING PRODRUGS

#620
20190099400
2019-04-04

Inhibitor of inflammasome activation

#621
20190099385
2019-04-04

Anti-fungal compounds

#622
20190091262
2019-03-28

Combined organ and hematopoietic cells for transplantation tolerance of grafts

#623
20190084994
2019-03-21

Hepatitis B antiviral agents

#624
20190083575
2019-03-21

THERAPEUTIC EFFECTS OF BRYOSTATINS, BRYOLOGS, AND OTHER RELATED SUBSTANCES ON HEAD TRAUMA-INDUCED MEMORY IMPAIRMENT AND BRAIN INJURY

#625
20190083530
2019-03-21

Combined organ and hematopoietic cells for transplantation tolerance of grafts

#626
20190083458
2019-03-21

Andrographolide treats progressive forms of multiple sclerosis

#627
20190083450
2019-03-21

Derivatives of korormicin useful as antibiotics

#628
20190077811
2019-03-14

Ginkgolide B derivative and preparation method and use thereof

#629
20190076498
2019-03-14

Feijoa fruit extract

#630
20190076468
2019-03-14

ENHANCED IMMUNE RESPONSE UPON TREATMENT WITH NITRIC OXIDE

#631
20190076416
2019-03-14

PIM kinase inhibitors in combination with RNA splicing modulators/inhibitors for treatment of cancers

#632
20190076387
2019-03-14

Composition and method for treatment of neurodegenerative diseases

#633
20190070158
2019-03-07

Veterinary composition comprising imidacloprid, moxidectin and praziquantel for cutaneous topical application (spot on), for the treatment and prevention of ecto and endoparasitoses affecting dogs

#634
20190070145
2019-03-07

USING FATTY ACID SYNTHASE INHIBITORS TO TREAT FIBROSIS

#635
20190054105
2019-02-21

Antitumor arylnaphthalene ligand glycosides

#636
20190046497
2019-02-14

METHODS OF MODULATING PROTEIN EXOCYTOSIS AND USES OF SAME IN THERAPY

#637
20190040032
2019-02-07

Molecule with anti-cancer activity

#638
20190038596
2019-02-07

Glucose conjugates of triptolide, analogs and uses thereof

#639
20190038588
2019-02-07

NOVEL CLASS OF COMPOUNDS FOR THE TREATMENT OF CARDIOVASCULAR DISEASE

#640
20190031674
2019-01-31

Quantification and preparation of pharmaceutical grade cantharidin

#641
20190029997
2019-01-31

Podophyllotoxin derivative with 4-position nitrogen substitution and preparation method and application thereof

#642
20190022121
2019-01-24

Modulators of zinc activated cation channel

#643
20190008872
2019-01-10

Method of treating refractory rheumatoid arthritis associated with p53 mutation

#644
20190008826
2019-01-10

Use of butylidenephthalide

#645
20190008821
2019-01-10

Methods for treating obesity

#646
20190000877
2019-01-03

Combined organ and hematopoietic cells for transplantation tolerance of HLA mismatched grafts

#647
20190000840
2019-01-03

Combinations for the treatment of cancer

#648
20190000817
2019-01-03

Methods and compositions for treating obesity and/or diabetes and for identifying candidate treatment agents

#649
20190000798
2019-01-03

Method for treating pulmonary fibrosis comprising application of dimethylamino micheliolide

#650
20190000750
2019-01-03

Hypotonic microbicidal formulations and methods of use

#651
20190000080
2019-01-03

Use of hibiscus acid and derivatives thereof as antimicrobials against antibiotic-resistant and non-antibiotic-resistant microorganisms

#652
20180369375
2018-12-27

Anti-LAG3 antibodies and antigen-binding fragments

#653
20180353468
2018-12-13

Multikinase inhibitors for use in the treatment of cancer

#654
20180353467
2018-12-13

Methods for treating angiogenesis related disorder

#655
20180353441
2018-12-13

COMPOSITIONS AND METHODS FOR TREATING LUNG DISEASES

#656
20180346435
2018-12-06

Tricyclic prodrugs

#657
20180344766
2018-12-06

Combined organ and hematopoietic cells for transplantation tolerance of grafts

#658
20180338963
2018-11-29

Donor organ pre-treatment formulation

#659
20180326022
2018-11-15

COMPOSITIONS AND METHODS FOR IMPROVING HEART FUNCTION AND TREATING HEART FAILURE

#660
20180325995
2018-11-15

Protocol for treatment of lupus nephritis

#661
20180325890
2018-11-15

Methods and pharmaceutical compostions for treating rhabdomyolysis

#662
20180319894
2018-11-08

USING COLIPASE INHIBITORS TO TREAT PANCREATITIS

#663
20180318264
2018-11-08

Ophthalmic pharmaceutical compositions and uses relating thereto

#664
20180311208
2018-11-01

Uses of butylidenephthalide

#665
20180311207
2018-11-01

Methods of treating hearing loss

#666
20180311154
2018-11-01

Gastric residence systems for sustained release of therapeutic agents and methods of use thereof

#667
20180297935
2018-10-18

Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereof

#668
20180296524
2018-10-18

Methods for detection and eradication of myeloid leukemia stem cells

#669
20180291033
2018-10-11

Transplantation therapies

#670
20180289728
2018-10-11

EGR1 targeting molecules for the treatment of inflammatory and hyperproliferative conditions

#671
20180280522
2018-10-04

Folate-conjugated molecules for delivery of toxic small molecule inhibitors to cancer cells and methods of use

#672
20180280462
2018-10-04

USE OF FLAXSEED AND FLAXSEED DERIVATIVES FOR TREATMENT OF NEUROLOGICAL DISORDERS AND VIRAL DISEASES

#673
20180280420
2018-10-04

Edible energy composition

#674
20180280346
2018-10-04

Compositions and methods for treating cancer

#675
20180280345
2018-10-04

Use of acyl-homoserine lactone derivatives as anti-thrombotic agents

#676
20180280344
2018-10-04

Conjugate of memantine and arctigenin, and composition and use thereof

#677
20180271888
2018-09-27

COMPOSITIONS AND METHODS FOR PARKINSON'S DISEASE THERAPY

#678
20180271886
2018-09-27

TREATMENT OF LYMPHANGIOLEIOMYOMATOSIS

#679
20180265536
2018-09-20

Use of avermectin derivative for increasing bioavailability and efficacy of macrocyclic lactones

#680
20180264107
2018-09-20

TREATMENT OF AUTOIMMUNE DISEASES

#681
20180263955
2018-09-20

C-Myc as a biomarker for tumor sensitivity to treatment with RNA polymerase II inhibition

#682
20180256550
2018-09-13

Target for treating hepatitis B virus

#683
20180251440
2018-09-06

Derivative of lactone A

#684
20180250264
2018-09-06

Compositions for improved NRF2 activation and methods of their use

#685
20180243425
2018-08-30

Lymph directing prodrugs

#686
20180243337
2018-08-30

Combined organ and hematopoietic cells for transplantation tolerance of grafts

#687
20180243327
2018-08-30

USE OF SECOISOLARICIRESINOL DIGLUCOSIDES (SDGs) AND RELATED COMPOUNDS FOR PROTECTION AGAINST RADIATION DAMAGE

#688
20180236016
2018-08-23

NEUROTRANSMITTER AND BRAIN MODULATING ORAL DELIVERY SYSTEM FOR ENHANCEMENT OF COGNITIVE FUNCTIONS AND ENERGY

#689
20180235922
2018-08-23

Pharmaceutical composition containing Bay 11-7082, parthenolide or a combination thereof for the treatment of obesity or cardiovascular diseases

#690
20180235883
2018-08-23

Nanoparticulate compositions for targeted delivery of acid labile, lipophilic prodrugs of cancer chemotherapeutics and their preparation

#691
20180228870
2018-08-16

Angiopoietin-based interventions for treating cerebral malaria

#692
20180228759
2018-08-16

Monoacylglycerols for use in conjunction with a lipase inhibitor and/or diets low in fat and/or calories

#693
20180221439
2018-08-09

Antimicrobial fusion peptides

#694
20180221410
2018-08-09

Combined organ and hematopoietic cells for transplantation tolerance of grafts

#695
20180217163
2018-08-02

TREATMENT OF NEURODEGENERATIVE CONDITIONS USING PKC ACTIVATORS AFTER DETERMINING THE PRESENCE OF THE APOE4 ALLELE

#696
20180208597
2018-07-26

Compounds for use in treating or preventing cancerous diseases

#697
20180207216
2018-07-26

Compositions and Methods for Treating Multi-Drug Resistant Malaria

#698
20180207136
2018-07-26

OPHTHALMIC PHARMACEUTICAL COMPOSITIONS AND USES RELATING THERETO

#699
20180207127
2018-07-26

Use of butylidenephthalide (Bdph), method of using the same, and method for preparing pharmaceutical composition containing the same

#700
20180193380
2018-07-12

Combined organ and hematopoietic cells for transplantation tolerance of grafts

#701
20180193379
2018-07-12

Combined organ and hematopoietic cells for transplantation tolerance of grafts

#702
20180193359
2018-07-12

Chemical entities that kill senescent cells for use in treating age-related disease

#703
20180185336
2018-07-05

PARASITICIDAL ORAL VETERINARY COMPOSITIONS COMPRISING SYSTEMICALLY-ACTING ACTIVE AGENTS, METHODS AND USES THEREOF

#704
20180185327
2018-07-05

FORMULATION COMPRISING PARTICLES AND A LIPASE INHIBITOR

#705
20180179193
2018-06-28

N-sulfonyl homoserine lactone derivatives, preparation method and use thereof

#706
20180179172
2018-06-28

Glucagon-like peptide 1 modulator and uses thereof

#707
20180177730
2018-06-28

Microspheres containing anthelmintic macrocyclic lactones

#708
20180171411
2018-06-21

GFRalpha1 AS A BIOMARKER FOR CISPLATIN-INDUCED CHEMORESISTANCE AND METASTASIS

#709
20180169108
2018-06-21

Drug Combinations For the Treatment of HIV

#710
20180162829
2018-06-14

Treprostinil derivative compounds and methods of using same

#711
20180161305
2018-06-14

Acetogenin molecules having antiplatelet and/or antithrombic activities, and methods and compositions thereof

#712
20180155360
2018-06-07

Ether analogues of galiellalactone

#713
20180153854
2018-06-07

Non-aromatic difluoro analogues of resorcylic acid lactones

#714
20180147250
2018-05-31

Synthetic substrates for enzymes that catalyze reactions of modified cysteines and related methods

#715
20180147180
2018-05-31

Devices and methods for facilitating and controlling use of a medication

#716
20180140574
2018-05-24

PARTHENOLIDE AND ITS DERIVATIVE FOR USE IN THE TREATMENT OF AXONAL DAMAGE

#717
20180133677
2018-05-17

Apparatus for a mass production of monodisperse biodegradeable polymer-based microspheres and a multi-channel forming device incorporatable therein

#718
20180133672
2018-05-17

Apparatus for a mass production of monodisperse biodegradable polymer-based microspheres and a multi-channel forming device incorporatable therein

#719
20180133155
2018-05-17

Combination HIV therapeutic

#720
20180128816
2018-05-10

Reagents and Methods for Cancer Treatment and Prevention

#721
20180127752
2018-05-10

Therapeutics targeting IGFBP7 for the treatment or prevention of heart failure and metabolic diseases

#722
20180125815
2018-05-10

CDC7 kinase inhibitors and uses thereof

#723
20180117118
2018-05-03

Compositions and methods of improved wound healing

#724
20180098956
2018-04-12

THERAPEUTIC COMPOSITIONS

#725
20180094038
2018-04-05

Acylated glucagon analogue

#726
20180085345
2018-03-29

METHODS OF TRACKING SKIN CONDITIONS USING CYCLOLIGNAN COMPOUNDS

#727
20180065946
2018-03-08

Miliusanes as antiviral agents

#728
20180064774
2018-03-08

Compositions for use in the treatment of tumors resistant to chemotherapy

#729
20180064680
2018-03-08

Derivatives of korormicin useful as antibiotics

#730
20180055926
2018-03-01

Combination of local rose bengal and systemic immunomodulative therapies for enhanced treatment of cancer

#731
20180055816
2018-03-01

PYRANONAPHTHOQUINONE COMPOUNDS AND METHODS OF USE THEREOF

#732
20180051314
2018-02-22

Compounds, substrates and methods related to histone deacetylases

#733
20180050016
2018-02-22

Compositions and methods to treat niemann-pick disease

#734
20180049981
2018-02-22

Preparation of an oil-in-water emulsion for polymer stabilized pharmaceutical formulations

#735
20180043017
2018-02-15

PHARMACEUTICAL COMPOSITIONS COMPRISING 0.5 MG DOSE OF SYNTHETIC HUMAN PEPTIDES FOR TREATING SYSTEMIC LUPUS ERYTHEMATOSUS

#736
20180042884
2018-02-15

Compositions for use in treating glioblastoma

#737
20180036292
2018-02-08

PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BACTERIAL INFECTIONS

#738
20180036277
2018-02-08

C14-hydroxyl esterified amino acid derivative of triptolide, and preparation method and use thereof

#739
20180030132
2018-02-01

Methods of treatment using an interferon gamma inhibitor

#740
20180028550
2018-02-01

Use of albiflorin or pharmaceutically acceptable salt for prevention and/or treatment of irritable bowel syndrome

#741
20180028489
2018-02-01

Stable cannabinoid formulations

#742
20180022878
2018-01-25

Facile assembly of soft nanoarchitectures and co-loading of hydrophilic and hydrophobic molecules via flash nanoprecipitation

#743
20180021435
2018-01-25

Hypotonic hydrogel formulations for enhanced transport of active agents at mucosal surfaces

#744
20180021411
2018-01-25

Composition and method for improving sleep duration and quality

#745
20180016601
2018-01-18

Methods for Modulating Genome Editing

#746
20180015084
2018-01-18

Use of flibanserin in the treatment of obesity

#747
20180002699
2018-01-04

Compositions and methods for reactivating latent immunodeficiency virus

#748
20180002399
2018-01-04

FGFR1 EXTRACELLULAR DOMAIN COMBINATION THERAPIES

#749
20180000885
2018-01-04

Therapeutic Nanoparticles With High Molecular Weight Copolymers

#750
20170369462
2017-12-28

Modulation of Bacterial Quorum Sensing with Synthetic Ligands

#751
20170368088
2017-12-28

Treatment of filarial diseases

#752
20170368010
2017-12-28

Neprilysin inhibitors

#753
20170362166
2017-12-21

β-substituted β-amino acids and analogs as chemotherapeutic agents and uses thereof

#754
20170360789
2017-12-21

FAS inhibitors and methods associated therewith

#755
20170360746
2017-12-21

Polymorph of granaticin B

#756
20170360715
2017-12-21

Modified release composition of orlistat and acarbose for the treatment of obesity and related metabolic disorders

#757
20170354639
2017-12-14

DITERPENOID DERIVATIVES AND METHODS OF USE THEREOF

#758
20170348317
2017-12-07

Treatment of solid tumours

#759
20170348278
2017-12-07

Ecteinamycin, compositions and uses thereof

#760
20170348267
2017-12-07

Soothing composition for animals, comprising at least one fatty acid and nepetalactone

#761
20170348266
2017-12-07

Inhibition of proline catabolism for the treatment of cancer and other therapeutic applications

#762
20170343564
2017-11-30

Fibroblast growth factor receptors as diagnostic markers of acquired sensory neuronopathies

#763
20170340689
2017-11-30

TITRATED EXTRACTS OF CYNARA SCOLYMUS FOR USE IN THE TREATMENT OF MESOTHELIOMA

#764
20170340600
2017-11-30

Compositions, methods of use, and methods of treatment

#765
20170333478
2017-11-23

Use of Z-butylidenephthalide in activating autoimmune system

#766
20170333391
2017-11-23

Method for delaying the onset of pulmonary fibrosis or treating pulmonary fibrosis

#767
20170333373
2017-11-23

Glutarate compounds for treating ischemia-reperfusion injuries

#768
20170326103
2017-11-16

Lymph directing prodrugs

#769
20170319542
2017-11-09

Pharmaceutical composition containing Ginkgolide B and Xa factor inhibitor, preparation method thereof and use thereof

#770
20170319541
2017-11-09

METHODS OF STIMULATING CELLULAR GROWTH, SYNAPTIC REMODELING AND CONSOLIDATION OF LONG-TERM MEMORY

#771
20170313669
2017-11-02

LACTONE COMPOUNDS AND METHODS OF MAKING AND USING SAME

#772
20170312284
2017-11-02

Analogs of adenosine monophosphate (AMP) as inhibitors of ubiquitin-like modifier-activating enzyme ATG7

#773
20170312256
2017-11-02

TRANSDERMAL PARASITICIDAL FORMULATIONS

#774
20170312248
2017-11-02

Pharmaceutical composition containing Ginkgolide B and ADP receptor antagonist, preparation method thereof and use thereof

#775
20170306015
2017-10-26

Binding molecules, especially antibodies, binding to L1CAM (CD171)

#776
20170304340
2017-10-26

Compound of the avermectin family or of the milbemycin family for the treatment and/or prevention of atopic dermatitis

#777
20170304310
2017-10-26

Methods and compositions for the inhibition of Pin1

#778
20170304293
2017-10-26

Coordinated metabolic reprogramming in response to productive viral infections

#779
20170303538
2017-10-26

Antimicrobial, disinfecting, and wound healing compositions and methods for producing and using the same

#780
20170296502
2017-10-19

Methods and compositions for increasing the potency of antifungal agents

#781
20170290768
2017-10-12

Compositions and methods for selective GI tract delivery

#782
20170290766
2017-10-12

Soft chewable pharmaceutical products

#783
20170281649
2017-10-05

Chemical entities that kill senescent cells for use in treating age-related disease

#784
20170281557
2017-10-05

Drug-containing particulate composition with cationic agent, associated medical devices, and methods for treatment

#785
20170275263
2017-09-28

Compounds for the treatment of HPV-induced carcinoma

#786
20170274077
2017-09-28

Methods for increasing red blood cell levels and treating ineffective erythropoiesis

#787
20170273993
2017-09-28

Pharmaceutical composition containing Ginkgolide B and blood platelet prostaglandin cyclooxygenase inhibitor and method for preparation thereof and use thereof

#788
20170266295
2017-09-21

Controlled drug release liposome compositions and methods thereof

#789
20170266156
2017-09-21

METHOD FOR PREVENTING CANCER BY USING PHTHALIDES

#790
20170266155
2017-09-21

Method for enhancing the oxygenation level of tissue cells as an alternative method for hyperbaric oxygen therapy

#791
20170266154
2017-09-21

METHOD FOR TREATING ALZHEIMER'S DISEASE AND 2, 3-BIPHOSPHOGLYCERATE METABOLISM DISORDER INDUCED

#792
20170258917
2017-09-14

Solubility of therapeutic agents

#793
20170253609
2017-09-07

Hepatitis B antiviral agents

#794
20170246174
2017-08-31

Methods of treatment of malignancies

#795
20170246145
2017-08-31

Use of Artemisinin for Treating Tumors Induced by Oncogenic Viruses and for Treating Viral Infections

#796
20170239212
2017-08-24

BRYOSTATIN ANALOGS AND USE THEREOF AS ANTIVIRAL AGENTS

#797
20170232032
2017-08-17

Pharmaceutical compositions for treating ebola virus disease

#798
20170231962
2017-08-17

Compound combinations for attenuation of bacterial virulence

#799
20170231950
2017-08-17

Composition and method to treat and alleviate symptoms of hot flashes in a female subject

#800
20170224816
2017-08-10

METHODS FOR REDUCING LDL-CHOLESTEROL

#801
20170224651
2017-08-10

Aromatic farnesyl compound and application thereof

#802
20170224623
2017-08-10

APPLICATION OF ANDROGRAPHOLIDE IN THE PREPARATION OF A PHARMACEUTICAL FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE, ANDROGRAPHOLIDE ENTERIC TARGETING MICROPELLET, AND METHOD FOR PREPARATION THEREOF

#803
20170224622
2017-08-10

APPLICATION OF ANDROGRAPHOLIDE IN THE PREPARATION OF A PHARMACEUTICAL FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE, ANDROGRAPHOLIDE ENTERIC TARGETING MICROPELLET, AND METHOD FOR PREPARATION THEREOF

#804
20170209412
2017-07-27

Treatment of sickle cell disease

#805
20170209411
2017-07-27

Use of butylidenephthalide (Bdph), method of using the same, and method for preparing pharmaceutical composition containing the same

#806
20170198359
2017-07-13

METHODS AND COMPOSITIONS FOR TREATMENT OR DIAGNOSIS OF CANCERS RELATED TO GABRA3

#807
20170196920
2017-07-13

Compositions and Related Methods For Treating Hyperadrenocorticism

#808
20170182001
2017-06-29

Sesquiterpene derivatives and their use in inflammation or cancer treatment

#809
20170172978
2017-06-22

METHODS AND COMPOSITIONS FOR TREATMENT OF LIPID STORAGE DISORDERS

#810
20170165308
2017-06-15

Use of a composition for lowering cholesterol level in a mammal, a method for its preparation and a product and a food additive comprising said composition

#811
20170157084
2017-06-08

Use of composition for modulating angiogenesis

#812
20170140094
2017-05-18

Method for determining the risk profile of neoplastic tissue

#813
20170137883
2017-05-18

Method for diagnosing subclinical and clinical acute rejection by analysis of predictive gene sets

#814
20170128434
2017-05-11

NOVEL ESTROGEN RECEPTOR LIGANDS

#815
20170119806
2017-05-04

ARYLNAPHTHALENE LACTONE DERIVATIVES AND METHODS OF MAKING AND USING THEREOF

#816
20170119731
2017-05-04

CDC7 kinase inhibitors and uses thereof

#817
20170119721
2017-05-04

Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof

#818
20170112843
2017-04-27

Compounds and methods for inducing chondrogenesis

#819
20170106086
2017-04-20

Combined organ and hematopoietic cells for transplantation tolerance of HLA mismatched grafts

#820
20170105965
2017-04-20

PPAR-gamma activator

#821
20170100448
2017-04-13

TREATMENT OF THE COMPLICATIONS OF CHRONIC LIVER DISEASE WITH CASPASE INHIBITORS

#822
20170100414
2017-04-13

Small molecule efflux pump inhibitors

#823
20170100377
2017-04-13

Solid Oral Pharmaceutical Compositions for Isoxazoline Compounds

#824
20170095524
2017-04-06

METHODS FOR MODULATING CANCER CELLS AND STEM CELLS

#825
20170081303
2017-03-23

Treprostinil derivative compounds and methods of using same

#826
20170079948
2017-03-23

Compositions and methods to treat Niemann-Pick disease

#827
20170071994
2017-03-16

Medicinal ambrosia maritima extracts

#828
20170065599
2017-03-09

Therapy for constipation

#829
20170065552
2017-03-09

Ophthalmic formulations of mycophenolic acid

#830
20170056506
2017-03-02

Amphiphilic drug-drug conjugates for cancer therapy, compositions and methods of preparation and uses thereof

#831
20170056370
2017-03-02

Composition comprising 7-hydroxymatairesinol

#832
20170049836
2017-02-23

COMPOSITIONS COMPRISING BOTANICALS, INCLUDING THE USE AND METHOD OF USE THEREOF

#833
20170049793
2017-02-23

MOLECULAR ACTIVATORS OF THE WNT/BETA-CATENIN PATHWAY

#834
20170049746
2017-02-23

USES OF BUTYLIDENEPHTHALIDE

#835
20170042928
2017-02-16

Edible energy composition

#836
20170042815
2017-02-16

Nanoparticulate compositions for targeted delivery of acid labile, lipophilic prodrugs of cancer chemotherapeutics and their preparation

#837
20170036992
2017-02-09

Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereof

#838
20170035859
2017-02-09

Methods and compositions for treating nephrogenic diabetes insipidus

#839
20170035695
2017-02-09

Controlled release composition

#840
20170029436
2017-02-02

NEOSORAPHENS

#841
20170027904
2017-02-02

Composition and method to treat and alleviate symptoms of hot flashes in a female subject

#842
20170027865
2017-02-02

Dry pharmaceutical compositions for topical delivery of oral medications, nasal delivery and to treat ear disorders

#843
20170022197
2017-01-26

Antiparisitic dihydroazole compounds and compositions comprising same

#844
20170020955
2017-01-26

Anthelmintic combinations and methods of use thereof

#845
20170015644
2017-01-19

Tricyclic prodrugs

#846
20170014519
2017-01-19

Targeted therapeutics

#847
20170014469
2017-01-19

METHODS OF REACTIVATING A LATENT HUMAN IMMUNODEFICIENCY VIRUS

#848
20170014362
2017-01-19

ANTI-CHOLESTEROLEMIC COMPOUNDS AND METHODS OF USE

#849
20170008962
2017-01-12

Therapeutic peptides

#850
20170007584
2017-01-12

Stable veterinary anthelmintic formulations

#851
20170007547
2017-01-12

Spray-dried solid-in-oil-in-water dispersions for inhalation of active pharmaceutical ingredients

#852
20170000730
2017-01-05

Ophthalmic drug delivery method

#853
20160376524
2016-12-29

MUSK COMPOSITIONS AND METHODS OF USE THEREOF

#854
20160376523
2016-12-29

Musk compositions and methods of use thereof

#855
20160375078
2016-12-29

TOPICAL COMPOSITION COMPRISING NATURAL INGREDIENTS FOR BRUISING OR HEMATOMA HEALING ON SKIN AND USE THEREOF

#856
20160374994
2016-12-29

Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof

#857
20160367525
2016-12-22

Uses of sesquiterpene lactone compounds and their derivatives in drugs preparation

#858
20160367524
2016-12-22

Use of Lappaol F to inhibit tumor cell growth

#859
20160356787
2016-12-08

LKB1 related diagnostics and treatments of cancer

#860
20160356773
2016-12-08

Methods and systems for modulating hormones and related methods, agents and compositions

#861
20160354397
2016-12-08

Methods and compounds for modulating the secretion or expression of adhesion proteins or angiopoietins of cells

#862
20160354339
2016-12-08

Method of treating MYC-amplified tumors with RNA-polymerase II inhibitors

#863
20160347730
2016-12-01

Methods of producing cancer targeting compounds

#864
20160347706
2016-12-01

Methods of producing cancer treating compounds

#865
20160346386
2016-12-01

Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation

#866
20160346309
2016-12-01

Treatment of viral infections by modulation of host cell metabolic pathways

#867
20160338988
2016-11-24

TOFA analogs useful in treating dermatological disorders or conditions

#868
20160338986
2016-11-24

Methods and compositions for preventing and treating auditory dysfunctions

#869
20160324926
2016-11-10

Use of CD83 in Combination Therapies

#870
20160324826
2016-11-10

Method for providing an increased expression of telomerase, brain-derived neurotrophic factor, stromal cell-derived factor-1, CXC chemokine receptor 4, and/or immune regulatory factor of stem cell

#871
20160324825
2016-11-10

Use of atractylenolide compound or its derivatives and a medicament for inhibiting platelet aggregation

#872
20160317670
2016-11-03

Targeted nanocarriers for the administration of immunosuppressive agents

#873
20160317575
2016-11-03

Anti-inflammatory compounds in combination with hydrogen for the treatment of inflammation

#874
20160317470
2016-11-03

Agent for inhibiting odor of pyrazine derivatives

#875
20160310477
2016-10-27

CANCER TREATMENTS USING COMBINATIONS OF MEK TYPE 1 AND ERK INHIBITORS

#876
20160304483
2016-10-20

Peloruside analogs

#877
20160303168
2016-10-20

Method for enhancing therapeutic effect of stem cells

#878
20160303157
2016-10-20

Method for preparing an anthelmintic composition, anthelmintic composition, veterinary treatment method and anthelmintic treatment method

#879
20160297830
2016-10-13

NOVEL COMPOUNDS USEFUL FOR THE TREATMENT OF BACTERIAL INFECTIOUS DISEASES

#880
20160297829
2016-10-13

METHOD FOR PRODUCING AVENACIOLIDES AND USES THEREOF

#881
20160297790
2016-10-13

Cytotoxin compounds and methods of isolation

#882
20160291027
2016-10-06

METHODS FOR PROGNOSING THE ABILITY OF A ZEARALENONE ANALOG COMPOUND TO TREAT CANCER

#883
20160289242
2016-10-06

Anilino podophyllin derivative having antitumor activity, method for preparation thereof, and use thereof

#884
20160287569
2016-10-06

COMBINATION THERAPY INCLUDING AN MDM2 INHIBITOR AND ONE OR MORE ADDITIONAL PHARMACEUTICALLY ACTIVE AGENTS FOR THE TREATMENT OF CANCERS

#885
20160279150
2016-09-29

Combination of selected analgesics and COX-II inhibitors

#886
20160279096
2016-09-29

Use of 15-benzylidence-14-deoxy-11, 12 -dehyroandrographolide derivative in manufacture of medicaments for protecting liver and anti-hepatitis C virus

#887
20160272603
2016-09-22

Trail enhancers for the selective killing of cancer cells

#888
20160271196
2016-09-22

Methods of treatment using extracts of

#889
20160271176
2016-09-22

Trace elements

#890
20160256432
2016-09-08

Compositions and methods of inhibiting N-acylethanolamine-hydrolyzing acid amidase

#891
20160250181
2016-09-01

Alternative ACT with natural botanical active GRAS ingredients for treatment and prevention of the Zika virus

#892
20160250178
2016-09-01

Compositions, methods of use, and methods of treatment

#893
20160250174
2016-09-01

Monoacylglycerols for use in conjunction with a lipase inhibitor and/or diets low in fat and/or calories

#894
20160243236
2016-08-25

HCD formulation for cancer treatment

#895
20160235862
2016-08-18

Vaults engineered for hydrophobic drug delivery

#896
20160235707
2016-08-18

DISUBSTITUTED BETA-LACTONES AS INHIBITORS OF N-ACYLETHANOLAMINE ACID AMIDASE (NAAA)

#897
20160228457
2016-08-11

Method for cancer cell reprogramming

#898
20160220566
2016-08-04

Parasiticidal compositions comprising multiple active agents, methods and uses thereof

#899
20160220510
2016-08-04

ANTIBIOTIC COMPOUNDS THAT INHIBIT BACTERIAL PROTEIN SYNTHESIS

#900
20160213702
2016-07-28

Glycan therapeutics and related methods thereof